New pill aims to quiet tourette tics in landmark trial

NCT ID NCT06315751

Ongoing Symptom relief Sponsor: Noema Pharma AG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an experimental drug called gemlapodect to see if it can safely reduce tics in people with Tourette syndrome. About 164 adults and teens with moderate to severe tics will take the drug or a placebo for 12 weeks. The main goal is to measure changes in tic severity using a standard rating scale.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Tourette syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TOURETTE SYNDROME

Contacts and locations

Locations

NOE-TTS-201 Site #25

Munich, 80336, Germany
NOE-TTS-201 Site #28

Seville, 41013, Spain
NOema TTS-201 Site #19

New York, New York, 10003, United States
Noema TTS-201 #07

Bron, 69677, France
Noema TTS-201 Site # 74

Miami, Florida, 33136, United States
Noema TTS-201 Site #03

Stony Brook, New York, 11794, United States
Noema TTS-201 Site #05

Hialeah, Florida, 33013, United States
Noema TTS-201 Site #06

Ghent, 9000, Belgium
Noema TTS-201 Site #08

Poitiers, 86000, France
Noema TTS-201 Site #09

Hanover, 30625, Germany
Noema TTS-201 Site #13

Katowice, 40097, Poland
Noema TTS-201 Site #14

Katowice, 40123, Poland
Noema TTS-201 Site #15

Burgos, 09006, Spain
Noema TTS-201 Site #16

Sant Cugat del Vallès, 08190, Spain
Noema TTS-201 Site #17

Oviedo, 33011, Spain
Noema TTS-201 Site #18

Petersburg, Virginia, 23805, United States
Noema TTS-201 Site #21

Walnut Creek, California, 94596, United States
Noema TTS-201 Site #22

Fort Worth, Texas, 76104, United States
Noema TTS-201 Site #26

Barcelona, 08041, Spain
Noema TTS-201 Site #27

Madrid, 28922, Spain
Noema TTS-201 Site #30

Budapest, 1013, Hungary
Noema TTS-201 Site #35

Düsseldorf, 40225, Germany
Noema TTS-201 Site #42

Dallas, Texas, 75243, United States
Noema TTS-201 Site #44

Maitland, Florida, 32751, United States
Noema TTS-201 Site #45

Orem, Utah, 84097, United States
Noema TTS-201 Site #50

Bellevue, Washington, 98007, United States
Noema TTS-201 Site #51

Ann Arbor, Michigan, 48105, United States
Noema TTS-201 Site #54

Gulf Breeze, Florida, 32561, United States
Noema TTS-201 Site #55

Boston, Massachusetts, 02114, United States
Noema TTS-201 Site #56

Miami Lakes, Florida, 33016, United States
Noema TTS-201 Site #57

Charlotte, North Carolina, 28211, United States
Noema TTS-201 Site #58

Middleburg Heights, Ohio, 44130, United States
Noema TTS-201 Site #59

San Rafael, California, 94903, United States
Noema TTS-201 Site #61

Orlando, Florida, 32802, United States
Noema TTS-201 Site #71

Largo, Florida, 33777, United States
Noema TTS-201 Site #73

North Charleston, South Carolina, 29405, United States
Noema TTS-201 Site #75

Glendale, California, 91203, United States
Noema TTS-201 Site #79

Atlanta, Georgia, 30318, United States
Noema TTS-201 Site #81

Sun City, Arizona, 85351, United States
Noema TTS-201 Site #87

Peachtree Corners, Georgia, 30071, United States
Noema TTS-201 Site #93

Lincoln, Nebraska, 68526, United States
Noema TTS-201 Site #94

San Antonio, Texas, 78249, United States
Noema TTS-201 Site #95

Bellflower, California, 90706, United States
Noema TTS-201 Site #96

Saint Charles, Missouri, 63304, United States
Noema TTS-201 Site #97

Jensen Beach, Florida, 34957, United States
Noema TTS-201 Site #98

Nashville, Tennessee, 37203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.